Current News
July 29, 2010
Synthes First Half 2010: Solid Growth and Improved Profitability
April 29, 2010
Synthes Reports Q1 2010 Sales Performance with 13% Growth (9% in local currency)
Company Profile for Investors
Synthes, headquartered in West Chester, PA (USA), is a leading global medical device company, employing over 10,700 people to improve patient care around the world. In 2009, Synthes generated revenues of US$ 3.4 billion and net earnings of US$ 824 million.
Through its five product groups (Trauma, Spine, Cranio-Maxillofacial, Biomaterials and Power Tools), Synthes develops, produces and markets instruments, implants and biomaterials for the surgical fixation, correction and regeneration of the human skeleton and its soft tissues.
The company operates in product markets with high growth, driven by the ageing population and improvements in technology that allow treating more patients with better implants.
Over the last 10 years (2000–2009) Synthes has increased its revenues from US$ 786 million to US$ 3.4 billion, representing a CAGR of 18%, including the acquisition of Mathys in 2004.